LEADERSHIP AND STRATEGY

Resilience Partners with Takeda's Plasma-Derived Therapies Business Unit on Multi-Product Development and Manufacturing

Resilience | February 16, 2022

On February 15, National Resilience, Inc. (Resilience), a technology-focused manufacturing firm devoted to expanding access to complicated medications, signed a deal with Takeda's Plasma-Derived Therapies Business Unit to provide manufacturing services.

As part of the deal, Resilience will assist in developing and manufacturing numerous products in Takeda's plasma-derived pharmaceuticals portfolio from its plant in Mississauga, Ontario.

 "I'm proud to establish this relationship with Takeda, a company that has been pioneering plasma-derived therapies for more than 75 years. By bringing new technologies and innovation to biomanufacturing, we aim to help companies like Takeda reach more patients in need."

-Rahul Singhvi, Sc.D., and Chief Executive Officer of Resilience

In Mississauga, Resilience's 136,000 square foot (12,800 square meters) biomanufacturing plant provides process and analytical development, scale-up, drug substance, and drug product/fill manufacturing for various pharmaceuticals.

"Takeda is delighted to form this strategic collaboration with Resilience, leveraging their expertise in both plasma therapy development and manufacturing to complement our current infrastructure and capabilities,We will be able to use our combined resources to help us grow our portfolio, drive innovation, and help more patients around the world benefit from plasma medicines."

-Andreas Liebminger, Head of Pharmaceutical Sciences and Devices for the Plasma-Derived Therapies Business Unit at Takeda. 

Spotlight

Over the past several years, the fiber-optic industry has faced many challenges in the production of critical components. One can argue that the downturn—by making it unnecessary to scramble to meet ambitious production quotas—offers a good opportunity to review current production methods. In this context, it is clear that many of the manual processes used in manufacturing fiber-optic components have significantly contributed to the present situation. In North America, only 5-10% of installed fiber-optic cable is actually being used to transmit data. A precursor to higher usage rates will be resolution of the production challenges the industry now faces.

Spotlight

Over the past several years, the fiber-optic industry has faced many challenges in the production of critical components. One can argue that the downturn—by making it unnecessary to scramble to meet ambitious production quotas—offers a good opportunity to review current production methods. In this context, it is clear that many of the manual processes used in manufacturing fiber-optic components have significantly contributed to the present situation. In North America, only 5-10% of installed fiber-optic cable is actually being used to transmit data. A precursor to higher usage rates will be resolution of the production challenges the industry now faces.

Related News

IOhub™ IIoT Orchestrator Is Now Available on Siemens Simatic Devices

IOhub | June 24, 2021

Because of its simplicity of use, flexibility, and affordability, IOhub by EZ VPN is rapidly gaining popularity with system integrators and machine builders worldwide. EZ VPN makes IOhub available on Siemens Simatic IPC127E devices in response to strong customer demand. IOhub is a modular orchestrator and communication runtime that enables the development of IIoT applications without coding. IOhub enables developing Industry 4.0 applications and integrating heterogeneous PLCs, field sensors, and software easier and more inexpensive. The availability of IOhub features and advantages on the Siemens Simatic IPC127E will accelerate IOhub's adoption as an IIoT orchestrator and communication solution. The flexibility of IOhub A big automation client asked EZ VPN's European team to provide a significant number of installations with IOhub as a data management and integration solution. IOhub has to be installed on a Siemens-branded hardware device to meet the customer's standards and needs. In keeping with its goal, EZ VPN aims to keep its technology open and simple to use by making IOhub accessible on various platforms and making EZ VPN application modules available for free. Customers are not compelled to utilize proprietary languages, frameworks, SDKs, runtimes, and so on but instead benefit from the flexibility of an open-source Docker container orchestrator, such as IOhub. The complexity of creating environments, installing, deploying, configuring, maintaining, and monitoring system statuses are hidden on the back end with IOhub, while preserving the dependability and security of an open-source solution.

Read More

SKF consolidates manufacturing and organisational structure in France

SKF | November 03, 2020

SKF today announces a consolidation and restructuring of various manufacturing, business and administrative functions in France. Consequently, manufacturing of slewing bearings would be moved from Avallon to St-Cyr-sur-Loire, resulting in the proposed closure of the Avallon factory. The transfer of production from Avallon to St-Cyr enables a more competitive and flexible offer to customers, as well as the realisation of synergies from the existing service centre and logistics capabilities in Saint-Cyr. Kent Viitanen, President, Bearing Operations, says: "We have announced a number of factory consolidations during the year and whilst these are difficult decisions to take, they are necessary to ensure we can continue to meet the needs of our customers in terms of competitiveness, flexibility and quality. We are committed to working with our employees to ensure a smooth transition into training programmes and new employment opportunities." The Avallon site currently has 140 employees and activities are expected to stop by the end of 2022. The restructuring of manufacturing, business and administrative functions in France is expected to impact approximately 110 employees.

Read More

Lygos Joins BioMADE Network to Advance Bioindustrial Manufacturing Technologies

Lygos | November 04, 2020

Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it has joined the Bioindustrial Manufacturing And Design Ecosystem (BioMADE), a nonprofit Manufacturing Innovation Institute (MII) and network of public-private entities created by the Engineering Biology Research Consortium (EBRC). BioMADE is working together with Lygos and other manufacturers and innovators to advance bioindustrial manufacturing technologies while simultaneously enhancing the structure of the entire innovation ecosystem across the country. BioMADE was recently awarded $87 million from the Department of Defense to promote and secure long-term US biotechnology innovation. The collaborative institute will develop predictive downstream processing and scale-up to help accelerate prototyping capabilities and reduce the time, risk, and cost of bringing bio-based products, such as Lygos’ organic acids and cannabinoids, to commercial scale.

Read More